Post-translational modifications and the Warburg effect

被引:109
作者
Hitosugi, T. [1 ]
Chen, J. [2 ]
机构
[1] Mayo Clin, Dept Oncol, Div Oncol Res, Rochester, MN USA
[2] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Winship Canc Inst Emory, Atlanta, GA 30322 USA
关键词
the Warburg effect; post-translational modifications; cancer metabolism; PYRUVATE-KINASE M2; PHOSPHOGLYCERATE MUTASE; TYROSINE PHOSPHORYLATION; NUCLEAR TRANSLOCATION; LACTATE-DEHYDROGENASE; GLYCOLYTIC-ENZYMES; METABOLIC TRANSFORMATION; GENE-TRANSCRIPTION; 3T3-L1; ADIPOCYTES; CELL METABOLISM;
D O I
10.1038/onc.2013.406
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Post-translational modification (PTM) is an important step of signal transduction that transfers chemical groups such as phosphate, acetyl and glycosyl groups from one protein to another protein. As most of the PTMs are reversible, normal cells use PTMs as a 'switch' to determine the resting and proliferating state of cells that enables rapid and tight regulation of cell proliferation. In cancer cells, activation of oncogenes and/or inactivation of tumor suppressor genes provide continuous proliferative signals in part by adjusting the state of diverse PTMs of effector proteins that are involved in regulation of cell survival, cell cycle and proliferation, leading to abnormally fast proliferation of cancer cells. In addition to dysregulated proliferation, 'altered tumor metabolism' has recently been recognized as an emerging cancer hallmark. The most common metabolic phenotype of cancer is known as the Warburg effect or aerobic glycolysis that consists of increased glycolysis and enhanced lactate production even in the presence of oxygen. Although Otto Warburg observed aerobic glycolysis nearly 90 years ago, the detailed molecular mechanisms how increased glycolysis is regulated by oncogenic and/or tumor suppressive signaling pathways remain unclear. In this review, we summarize recent advances revealing how these signaling pathways reprogram metabolism through diverse PTMs to provide a metabolic advantage to cancer cells, thereby promoting tumor cell proliferation, tumorigenesis and tumor growth.
引用
收藏
页码:4279 / 4285
页数:7
相关论文
共 71 条
  • [1] Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis
    Anastasiou, Dimitrios
    Yu, Yimin
    Israelsen, William J.
    Jiang, Jian-Kang
    Boxer, Matthew B.
    Hong, Bum Soo
    Tempel, Wolfram
    Dimov, Svetoslav
    Shen, Min
    Jha, Abhishek
    Yang, Hua
    Mattaini, Katherine R.
    Metallo, Christian M.
    Fiske, Brian P.
    Courtney, Kevin D.
    Malstrom, Scott
    Khan, Tahsin M.
    Kung, Charles
    Skoumbourdis, Amanda P.
    Veith, Henrike
    Southall, Noel
    Walsh, Martin J.
    Brimacombe, Kyle R.
    Leister, William
    Lunt, Sophia Y.
    Johnson, Zachary R.
    Yen, Katharine E.
    Kunii, Kaiko
    Davidson, Shawn M.
    Christofk, Heather R.
    Austin, Christopher P.
    Inglese, James
    Harris, Marian H.
    Asara, John M.
    Stephanopoulos, Gregory
    Salituro, Francesco G.
    Jin, Shengfang
    Dang, Lenny
    Auld, Douglas S.
    Park, Hee-Won
    Cantley, Lewis C.
    Thomas, Craig J.
    Heiden, Matthew G. Vander
    [J]. NATURE CHEMICAL BIOLOGY, 2012, 8 (10) : 839 - 847
  • [2] Inhibition of Pyruvate Kinase M2 by Reactive Oxygen Species Contributes to Cellular Antioxidant Responses
    Anastasiou, Dimitrios
    Poulogiannis, George
    Asara, John M.
    Boxer, Matthew B.
    Jiang, Jian-kang
    Shen, Min
    Bellinger, Gary
    Sasaki, Atsuo T.
    Locasale, Jason W.
    Auld, Douglas S.
    Thomas, Craig J.
    Vander Heiden, Matthew G.
    Cantley, Lewis C.
    [J]. SCIENCE, 2011, 334 (6060) : 1278 - 1283
  • [3] Oncogenic kinase signalling
    Blume-Jensen, P
    Hunter, T
    [J]. NATURE, 2001, 411 (6835) : 355 - 365
  • [4] A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth
    Bonnet, Sebastien
    Archer, Stephen L.
    Allalunis-Turner, Joan
    Haromy, Alois
    Beaulieu, Christian
    Thompson, Richard
    Lee, Christopher T.
    Lopaschuk, Gary D.
    Puttagunta, Lakshmi
    Bonnet, Sandra
    Harry, Gwyneth
    Hashimoto, Kyoko
    Porter, Christopher J.
    Andrade, Miguel A.
    Thebaud, Bernard
    Michelakis, Evangelos D.
    [J]. CANCER CELL, 2007, 11 (01) : 37 - 51
  • [5] Hypoxia signalling controls metabolic demand
    Brahimi-Horn, M. Christiane
    Chiche, Johanna
    Pouyssegur, Jacques
    [J]. CURRENT OPINION IN CELL BIOLOGY, 2007, 19 (02) : 223 - 229
  • [6] MECHANISM OF 2,3-DIPHOSPHOGLYCERATE-DEPENDENT PHOSPHOGLYCERATE MUTASE FROM RABBIT MUSCLE
    BRITTON, HG
    CLARKE, JB
    [J]. BIOCHEMICAL JOURNAL, 1972, 130 (02) : 397 - &
  • [7] The role of p53 in glucose metabolism
    Cheung, Eric C.
    Vousden, Karen H.
    [J]. CURRENT OPINION IN CELL BIOLOGY, 2010, 22 (02) : 186 - 191
  • [8] Proteomic approaches to the characterization of protein thiol modification
    Chouchani, Edward T.
    James, Andrew M.
    Fearnley, Ian M.
    Lilley, Kathryn S.
    Murphy, Michael P.
    [J]. CURRENT OPINION IN CHEMICAL BIOLOGY, 2011, 15 (01) : 120 - 128
  • [9] The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
    Christofk, Heather R.
    Vander Heiden, Matthew G.
    Harris, Marian H.
    Ramanathan, Arvind
    Gerszten, Robert E.
    Wei, Ru
    Fleming, Mark D.
    Schreiber, Stuart L.
    Cantley, Lewis C.
    [J]. NATURE, 2008, 452 (7184) : 230 - U74
  • [10] Pyruvate kinase M2 is a phosphotyrosine-binding protein
    Christofk, Heather R.
    Vander Heiden, Matthew G.
    Wu, Ning
    Asara, John M.
    Cantley, Lewis C.
    [J]. NATURE, 2008, 452 (7184) : 181 - U27